First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort

被引：0
|
作者：
Tafenzi, H. A. [1 ,2 ]
Takniouine, Y. Ait [1 ,2 ]
Haag, E. K. [1 ,2 ]
Abdillahi, B. D. [1 ,2 ]
Choulli, F. [1 ,2 ]
Baladi, A. [1 ,2 ]
Essadi, I. [3 ]
Belbaraka, R. [1 ,2 ]
机构：
[1] Mohammed VI Univ Hosp, Dept Med Oncol, Marrakech, Morocco
[2] Cadi Ayyad Univ, Fac Med & Pharm, Marrakech, Morocco
[3] Avicenne Mil Hosp, Dept Med Oncol, Marrakech, Morocco
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
378P
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [31] Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer
    Reesink, Daan
    van Melick, Harm H. E.
    van der Nat, Paul
    Los, Maartje
    Horenblas, Simon
    van de Garde, Ewoudt M. W.
    Santeon MIBC Study Grp
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1551 - 1562
  • [32] FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Chase, Dana
    Liu, Jinan
    Moore-Schiltz, Laura
    Perhanidis, Jennifer
    Bulsara, Purva
    Patton, Gregory
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A33 - A33
  • [33] Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer
    Salani, Ritu
    Boyle, Tirza Areli Calderon
    Lim, Jonathan
    Schilder, Jeanne M.
    Hurteau, Jean A.
    Perhanidis, Jessica
    Golembesky, Amanda
    Backes, Floor J.
    FUTURE ONCOLOGY, 2025, 21 (02) : 213 - 219
  • [34] Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study
    Suzuki, Daniele Assad
    Morelle, Alessandra Menezes
    de Brito, Mayana Lopes
    Paes, Flavia Rocha
    Mattar, Andre
    Leal, Jorge H. Santos
    Simon, Sergio D.
    Lima, Ellias Magalhaes Abreu
    Werutsky, Gustavo
    Piotto, Gustavo H. Munhoz
    Bines, Jose
    Damiani, Lucas Petri
    Macedo, Ariane
    Campos, Ligia
    Buehler, Anna Maria
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [35] A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis
    Wu, Y.
    Dong, X.
    Li, E.
    Fan, Y.
    Dong, D.
    Shi, Y.
    Wang, M.
    Yang, N.
    Ou, F.
    Wang, J.
    Yang, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S920 - S920
  • [36] Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
    Lee, J. Y.
    Mai, V.
    Garcia, M.
    Cheng, S.
    Khan, K.
    Balaratnam, K.
    Thakral, A.
    Brown, M. C.
    Zhan, L.
    Corke, L.
    Leighl, N.
    Shepherd, F. A.
    Bradbury, P.
    Sacher, A.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S440 - S440
  • [37] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Real-world outcomes in patients with first-line and second-line therapy for advanced esophageal squamous cell carcinoma
    Ahn, Daniel
    Sidel, Michelle
    Panattoni, Laura
    Sacks, Naomi
    Hernandez, Jennifer
    Villacorta, Reginald
    FUTURE ONCOLOGY, 2022, 18 (30) : 3419 - 3433
  • [39] Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer
    Waterhouse, David
    Lam, Jenny
    Betts, Keith A.
    Yin, Lei
    Gao, Sophie
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lubinga, Solomon
    Stenehjem, David
    LUNG CANCER, 2021, 156 : 41 - 49
  • [40] Real-World Outcomes of Immunotherapy-Based Regimens in First-Line Advanced Non-Small Cell Lung Cancer
    Waterhouse, D.
    Lam, J.
    Betts, K. A.
    Yin, L.
    Gao, S.
    Yuan, Y.
    Hartman, J.
    Rao, S.
    Lubinga, S.
    Stenehjem, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S17 - S18
12345